Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...

NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

As an enterprise engaged in the development, manufacturing and commercialization of specialty plasma-derived therapeutics, ...

Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...

In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income ...

Granules India has announced that Sethu Madhavan Sankaran has resigned from the position of Senior Vice President & Head-API ...

Amneal Pharmaceuticals, Inc. ( NASDAQ: AMRX) Q4 2024 Earnings Conference Call February 28, 2025 8:30 AM ET ...

South Korean vaccine maker SK bioscience today revealed that it has received prior notification from the Pan American Health ...

Corneal Ulcer Treatment MarketThe global corneal ulcer treatment market is projected to grow at a CAGR of 5.2% from 2024 to 2034, reaching a market value of USD 1,601.1 million by 2034. In 2024, the ...

Women's Health Therapeutics Market Rising Awareness and Government Initiatives Drive Growth AUSTIN, TX, UNITED STATES, February 28, 202 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

ICICI Pru Regular Savings Fund - Direct (IDCW-Q) 34.54 2,03,104 1.10 ICICI Pru Regular Savings Fund - Direct (IDCW-M) 34.54 2,03,104 1.10 ICICI Pru Regular Savings Fund - Direct (IDCW-HY) 34.54 ...